ReGen Biologics, Inc. (RGBI) Responds to FDA Request for Additional Information on Pending 510(k)  
6/27/2007 2:59:48 AM

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) today announced that the Company has recently responded to the FDA’s request for additional information regarding the Company’s December 2006 510(k) pre-market notification for its collagen scaffold device.